These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 387584)

  • 21. Human tumor-specific immunity assayed by a computerized tube leukocyte adherence inhibition.
    Thomson DM; Tataryn DN; Lopez M; Schwartz R; MacFarlane JK
    Cancer Res; 1979 Feb; 39(2 Pt 2):638-43. PubMed ID: 83918
    [No Abstract]   [Full Text] [Related]  

  • 22. [Micromodification of the leukocyte adherence inhibition test for cancer patients].
    Kharkevich DD; Tabagari DZ; Savinov AIu
    Vopr Onkol; 1985; 31(7):17-21. PubMed ID: 3895734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mechanisms, kinetics and specificity of the leukocyte adherence inhibition test in breast cancer].
    Kharkevich DD; Polevaia EB; Derevnina NA; Sablikova IuA; Savinov AIu
    Eksp Onkol; 1985; 7(6):69-73. PubMed ID: 3910405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Use of the micromodified leukocyte adherence inhibition test in the diagnosis of breast cancer].
    Kharkevich DD; Sablikova IuA; Polevaia EB; Savinov AIu
    Lab Delo; 1985; (6):374-6. PubMed ID: 2413267
    [No Abstract]   [Full Text] [Related]  

  • 25. Characterization of murine tumor-associated antigens by the micro-leukocyte adherence inhibition assay.
    Howell JH; Russo AJ; Goldrosen MH
    Cancer Res; 1979 Feb; 39(2 Pt 2):612-8. PubMed ID: 83914
    [No Abstract]   [Full Text] [Related]  

  • 26. Demonstration of the microtest version of the leukocyte adherence inhibition assay.
    Goldrosen MH; Howell JH; Holyoke ED
    Cancer Res; 1979 Feb; 39(2 Pt 2):630-2. PubMed ID: 367588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunological exploration of cancer patients. II. Tumoral immunity].
    Cappelaere P; Demaille A; Adenis L
    Lille Med; 1973 Feb; 18(2):179-201. PubMed ID: 4581842
    [No Abstract]   [Full Text] [Related]  

  • 28. Leucocyte adherence inhibition test for the detection of cell-mediated immunity to malignant melanoma.
    Winter M; Nelson DS; Milton GW
    Aust N Z J Med; 1980 Aug; 10(4):405-9. PubMed ID: 7000060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Specific immunity in patients with carcinoma of the pancreas. Preliminary report].
    Mester M; Zuliani A; Scheinberg MA; Machado MC
    Rev Hosp Clin Fac Med Sao Paulo; 1983 Jun; 38(3):107-10. PubMed ID: 6364296
    [No Abstract]   [Full Text] [Related]  

  • 30. [Immunodiagnostic aspects of breast cancer. The phenomenon of leukocyte adherence inhibition].
    Fritze D; Fritze J; Kaufmann M; Drings P
    Minerva Med; 1978 Nov; 69(58):3963-7. PubMed ID: 740287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Demonstration of cellular immunity by means of the leukocyte adherence inhibition (LAI) test in female breast neoplasms].
    Fritze D; Ellinger K; Mayer D; Kaufmann M; Drings P; Döhnert G
    Verh Dtsch Ges Inn Med; 1978; (84):577-9. PubMed ID: 742076
    [No Abstract]   [Full Text] [Related]  

  • 32. Humoral antitumor immune responses in patients with breast cancer measured with the leukocyte adherence inhibition technique.
    Kotlar HK; Sanner T
    J Natl Cancer Inst; 1981 Feb; 66(2):265-71. PubMed ID: 7005505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leukocyte adherence inhibition and immunoreactivity in prostatic cancer. II. Tissue- and disease-specificity of antitumour cell-mediated immunity.
    Bhatti RA; Ablin RJ; Guinan PD
    Eur J Cancer (1965); 1979 Jan; 15(1):133-6. PubMed ID: 421713
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical significance of leukocyte adherence inhibition assay in early detection of breast cancer.
    Kovarík J; Lauerová L; Kudlicková Z; Ninger E; Zemanová D
    Arch Geschwulstforsch; 1981; 51(4):344-8. PubMed ID: 7032450
    [No Abstract]   [Full Text] [Related]  

  • 35. Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancer.
    Halliday WJ; Koppi TA; Khan JM; Davis NC
    J Natl Cancer Inst; 1980 Aug; 65(2):327-35. PubMed ID: 6157045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immunologic diagnosis of malignant neoplasms. I].
    Shuster J; Thomson DM; Fuks A; Gold P
    Union Med Can; 1980 Jun; 109(6):902-9. PubMed ID: 7008310
    [No Abstract]   [Full Text] [Related]  

  • 37. Correlations between the leukocyte adherence inhibition microassay and in vivo tests of transplantation resistance.
    Leveson SH; Howell JH; Paolini NS; Tan MH; Holyoke ED; Goldrosen MH
    Cancer Res; 1979 Feb; 39(2 Pt 2):582-6. PubMed ID: 367584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular and humoral factors involved in the mechanism of the micro-leukocyte adherence inhibition reaction.
    Goldrosen MH; Russo AJ; Howell JH; Leveson SH; Holyoke ED
    Cancer Res; 1979 Feb; 39(2 Pt 2):587-92. PubMed ID: 367585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical value of the tube leukocyte adherence inhibition assay in diagnosis and prognosis of breast cancer.
    Lopez MJ; O'Connor R; MacFarlane JK; Thomson DM
    Surg Forum; 1977; 28():125-7. PubMed ID: 364712
    [No Abstract]   [Full Text] [Related]  

  • 40. The use of cryopreserved lymphocytes in the leukocyte adherence inhibition assay. I. Evaluation of specificity of responses in cancer patients.
    Waldman SR; Yonemoto RH
    Int J Cancer; 1978 May; 21(5):542-51. PubMed ID: 350778
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.